Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure - 30/06/16
Doi : 10.1016/j.hfc.2016.03.010
Anthony J. Choi, MD a, Sunu S. Thomas, MD, MSc b, Jagmeet P. Singh, MD, DPhil a, ⁎ 
a Electrophysiology Laboratory, Cardiac Arrhythmia Service, Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA
b Heart Failure & Transplant Services, Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA
∗Corresponding author.
Résumé |
Patients with advanced heart failure are at high risk for progression of their disease and sudden cardiac death. The role of device therapy in this patient population continues to evolve and is directed toward improving cardiac pump function and/or reducing sudden arrhythmic death.
Le texte complet de cet article est disponible en PDF.Keywords : Heart failure, CIED, Defibrillator, Cardiac resynchronization therapy, Arrhythmia
Plan
© 2016
Elsevier Inc. Tous droits réservés.
Vol 12 - N° 3
P. 423-436 - juillet 2016 Retour au numéro
Article précédent
- Changing Role of Heart Transplantation
- Michelle M. Kittleson
- Home Inotropes and Other Palliative Care
- Mahazarin Ginwalla
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?